ENOV
What one share of Enovis holds
Orthopedic, Prosthetic and Surgical Appliances and Supplies
Enovis Corporation (the “Company”, “Enovis”, “we” or “us”) is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing, and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.
Enovis’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-03; the balance sheet is as of 2026-07-03.
| Sales | $40.07 |
|---|---|
| Profit | −$19.22 |
| Capex (buildings and equipment) | $3.60 |
| Free cash flow | $1.11 |
| Cash and investments | $0.22 |
| Debt | $22.28 |
| Book value | $25.61 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $77.58 | $3.12 | $1.54 | $4.47 | — | $70.78 |
| 2017 | $46.87 | $3.66 | $1.66 | $3.63 | — | $85.21 |
| 2018 | $54.47 | $3.48 | $1.73 | $3.89 | — | $83.64 |
| 2019 | $73.04 | −$11.66 | $2.75 | $0.12 | — | $87.45 |
| 2020 | $24.58 | $0.94 | $2.52 | $4.11 | — | $89.71 |
| 2021 | $27.89 | $1.40 | $2.04 | $4.92 | — | $88.65 |
| 2022 | $28.91 | −$0.25 | $1.95 | −$2.98 | — | $63.58 |
| 2023 | $31.33 | −$0.61 | $2.24 | $0.23 | — | $62.61 |
| 2024 | $38.13 | −$14.93 | $3.27 | −$1.22 | — | $45.86 |
| 2025 | $39.39 | −$20.75 | $3.46 | $0.35 | — | $26.05 |